Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
500.00    0.00 (0.00%)
Bid:
499.80
Ask:
500.50
Spread: 0.70 (0.14%)
Market Cap: £1.35b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

CONTRACT AWARDS

28 Mar 2013 14:05

RNS Number : 1634B
Chemring Group PLC
28 March 2013
 



FOR IMMEDIATE RELEASE 28 MARCH 2013

CHEMRING GROUP PLC

ALLOY SURFACES AND KILGORE FLARES AWARDED $26 MILLION COUNTERMEASURES CONTRACTS BY THE US DEPARTMENT OF DEFENSE

Chemring Group PLC ("Chemring") is pleased to announce that its US subsidiaries, Alloy Surfaces Company, Inc. and Kilgore Flares Company LLC, have been awarded contracts worth $26 million for the manufacture of M211, M206, MJU-7A/B and MJU-10/B decoy devices for the US Army and the US Air Force. Deliveries under the contracts are scheduled to begin in June 2013 and will continue into 2015. The M211 decoy order is valued at $6 million, and will be produced at Alloy Surfaces. The M206, MJU-7A/B and MJU-10/B contracts are valued at $20 million, and will be produced at Kilgore Flares.

Mark Papworth, Chief Executive of Chemring, commented: "We are very pleased to receive these contracts from the US Army and the US Air Force, which demonstrates their continued confidence and trust in our countermeasures. We are very proud to deliver the highest quality infra-red decoys to the US Department of Defense and our international customers."

The US Army and US Air Force use these decoys to protect all of their helicopters, and transport and fighter aircraft against man-portable air defense systems, commonly known as MANPADS.

-ENDS-

Chemring Group PLC

Rupert Pittman - Group Director of Communications and Investor Relations

01489 881880 / rupertp@chemring.co.uk

MHP Communications

Andrew Jaques / James White

0203 128 8100

Notes to Editors:

Chemring is a market leading manufacturing business supplying high technology electronics and energetic products to over sixty countries around the world. Chemring has a diverse portfolio of products that predominantly protect military people and platforms, providing insurance against a constantly changing threat. These range from countermeasures to protect aircraft, to ground penetrating radar to protect troops and vehicles from improvised explosive devices. Alloy Surfaces and Kilgore Flares are industry leaders in the design, development, and production of F-22, JSF and covert multi-spectral special material decoys. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSEEFDAFDSEID
Date   Source Headline
7th Aug 20237:00 amRNSTransaction in Own Shares
4th Aug 20234:16 pmRNSDirector/PDMR Shareholding
4th Aug 20234:15 pmRNSDirector/PDMR Shareholding
4th Aug 20237:00 amRNSTransaction in Own Shares
3rd Aug 20237:00 amRNSTransaction in Own Shares
2nd Aug 20237:00 amRNSTransaction in Own Shares
1st Aug 20239:26 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSShare buyback programme
3rd Jul 20237:00 amRNSDirector/PDMR Shareholding
21st Jun 20239:47 amRNSBlock listing Interim Review
13th Jun 20237:00 amRNSAppointment of non-executive director
6th Jun 20237:00 amRNSHalf year results to 30 April 2023
1st Jun 202310:28 amRNSTotal Voting Rights
24th May 20237:00 amRNSAppointment of Chief Financial Officer
2nd May 20232:51 pmRNSTotal Voting Rights
20th Apr 202312:02 pmRNSDirector Declaration
3rd Apr 20239:25 amRNSTotal Voting Rights
29th Mar 20237:00 amRNSContract Award
28th Mar 20233:29 pmRNSHolding(s) in Company
16th Mar 20234:23 pmRNSDoc re. Ordinary & Special Resolutions
15th Mar 20233:11 pmRNSResult of AGM
15th Mar 20237:00 amRNSAGM Trading Update
1st Mar 202310:33 amRNSTotal Voting Rights
24th Feb 20239:07 amRNSDirector Declaration
1st Feb 202310:10 amRNSTotal Voting Rights
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
23rd Jan 20237:00 amRNSDirectorate Change
16th Jan 202310:44 amRNSNotice of AGM
9th Jan 20237:10 amRNSDirector Declaration
3rd Jan 202310:54 amRNSTotal Voting Rights
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSDirector/PDMR Shareholding
19th Dec 20223:41 pmRNSBlock listing Interim Review
14th Dec 202212:31 pmRNSDirector/PDMR Shareholding
14th Dec 202212:28 pmRNSDirector/PDMR Shareholding
14th Dec 202212:27 pmRNSDirector/PDMR Shareholding
14th Dec 202212:25 pmRNSDirector/PDMR Shareholding
14th Dec 202212:23 pmRNSDirector/PDMR Shareholding
14th Dec 202212:20 pmRNSDirector/PDMR Shareholding
13th Dec 20227:00 amRNSFinal Results
1st Dec 202210:01 amRNSTotal Voting Rights
11th Nov 20222:30 pmRNSHolding(s) in Company
1st Nov 202210:02 amRNSTotal Voting Rights
18th Oct 20224:17 pmRNSHolding(s) in Company
6th Oct 20227:00 amRNSTrading Update
3rd Oct 20221:55 pmRNSAdditional Listings
3rd Oct 20229:36 amRNSTotal Voting Rights
12th Sep 20229:00 amRNSNotice of Results
1st Sep 20229:13 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.